Related Experiment Videos

Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal

M Reiss1, A C Sartorelli

  • 1Department of Medicine, Yale University School of Medicine, New Haven, Connecticut 06510.

Cancer Research
|December 15, 1987
PubMed

Insights

Type beta transforming growth factor (TGF beta) inhibits epidermal growth factor (EGF)-stimulated keratinocyte proliferation but promotes their maturation. Squamous carcinomas show resistance to TGF beta

Area of Science:

  • Cell Biology
  • Dermatology
  • Cancer Research

Background:

  • Type beta transforming growth factor (TGF beta) and epidermal growth factor (EGF) are key regulators of skin cell behavior.
  • Understanding their roles is crucial for addressing skin growth disorders and cancers.

Purpose of the Study:

  • To investigate the regulatory roles of TGF beta and EGF on human epidermal cell growth and differentiation.
  • To compare the effects on normal keratinocytes versus squamous carcinoma cells.

Main Methods:

  • Utilized postconfluent cultures of human neonatal epidermal cells and squamous carcinoma cells.
  • Administered TGF beta and EGF, individually and in combination.
  • Assessed cell proliferation, DNA synthesis, and markers of epidermal differentiation (involucrin synthesis, cornified cell envelope formation).

Main Results:

  • TGF beta alone did not affect cell proliferation or DNA synthesis.
  • EGF stimulated cell growth, an effect antagonized by TGF beta.
  • TGF beta inhibited normal keratinocyte maturation in a dose-dependent manner.
  • Combined TGF beta and EGF enhanced normal keratinocyte maturation.
  • Squamous carcinomas were largely resistant to TGF beta's inhibitory effects on growth and maturation induction by TGF beta and EGF.

Conclusions:

  • TGF beta acts as an inhibitor of keratinocyte proliferation stimulated by EGF.
  • TGF beta induces keratinocyte maturation, an effect that can be enhanced by EGF in normal cells.
  • Squamous carcinoma cells exhibit resistance to TGF beta's regulatory effects, suggesting a role in cancer progression.

Related Concept Videos